SENATE 148118th CongressSubmitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S1081; text: CR S1101-1103)

A resolution recognizing the heritage, culture, and contributions of American Indian, Alaska Native, and Native Hawaiian women in the United States.

Last Action: 3/30/2023

Actions

2023-03-01Placed on Senate Legislative Calendar under General Orders. Calendar No. 21.
2023-03-01Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
2023-03-01Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
2023-02-09Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
2023-01-30Read twice and referred to the Committee on the Judiciary.
2023-01-30Introduced in Senate

CRS Summary

As of 2023-03-01 (25)

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act

This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.

The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.

Cosponsors (8)

Chuck Grassley (R-IA)
Richard Durbin (D-IL)
Mike Braun (R-IN)
Richard Blumenthal (D-CT)
Ted Cruz (R-TX)
Cory Booker (D-NJ)
Jon Ossoff (D-GA)
Peter Welch (D-VT)

Subjects

Administrative remedies
Business ethics
Civil actions and liability
Competition and antitrust
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Licensing and registrations
Prescription drugs
Public participation and lobbying

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.